communityacquir
pneumonia
cap
lead
caus
morbid
mortal
worldwid
accord
estim
million
case
pneumonia
record
year
million
death
ill
highest
incid
case
children
younger
year
old
mortal
rate
declin
greatli
due
earli
accur
detect
etiolog
agent
togeth
time
initi
appropri
treatment
nowaday
golden
standard
cap
diagnosi
still
base
chest
radiographi
howev
broad
rang
chest
radiograph
chang
could
induc
variou
agent
singl
dual
bacteriumviru
mix
pathogen
coinfect
alter
chest
radiographi
help
specif
case
confirm
microbi
caus
pneumonia
current
diagnost
method
identifi
pathogen
cap
patient
frequent
lack
microbiolog
diagnosi
cap
impair
pathogendirect
antimicrobi
therapi
polymeras
chain
reaction
pcr
techniqu
shown
reliabl
diagnos
pathogen
especi
difficult
cultur
addit
pcr
method
high
sensit
specif
detect
multipl
microorgan
yield
result
faster
cultur
serolog
method
importantli
result
pcr
affect
prior
use
antibiot
find
indic
incid
viral
pneumonia
past
underestim
multipl
pcr
assay
detect
multipl
rna
dna
target
singl
tube
potenti
rapid
identif
complic
respiratori
viral
pathogen
convent
techniqu
microbi
detect
high
accuraci
time
laborintens
limit
rang
detect
subject
reli
much
technic
expertis
interpret
cytopath
effect
cpe
cell
cultur
direct
fluoresc
antibodi
assay
dfa
immunochromatograph
antigen
test
although
rapid
poor
sensit
detect
virus
serolog
method
also
low
sensit
therefor
assay
capabl
rapid
detect
accur
identif
multipl
pathogen
desir
filmarray
respiratori
panel
rp
multiplex
nucleic
acid
test
simultan
qualit
detect
identif
multipl
respiratori
viru
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
particularli
whole
process
take
hour
compar
multipl
pcr
filmarray
rp
provid
fast
result
filmarray
rp
emerg
method
rare
employ
clinic
specimen
detect
clinic
signific
diagnos
cap
spars
therefor
studi
evalu
capabl
filmarray
rp
simultan
identif
multipl
pathogen
microbi
yield
clinic
signific
cap
diagnosi
also
evalu
specimen
patient
first
second
affili
hospit
shantou
univers
medic
colleg
cap
confirm
radiolog
diagnosi
nasal
caviti
sampl
serum
collect
patient
januari
septemb
specimen
collect
nasal
mucu
store
swab
storag
solut
copan
itali
multiplex
pcr
filmarray
rp
assay
nucleic
acid
extract
use
bead
viral
dnarna
extract
kit
tianlong
china
nucleic
acid
extract
instrument
tianlong
china
test
virus
includ
influenza
virus
type
b
flu
flu
b
parainfluenza
virus
respiratori
syncyti
viru
rsv
coronavirus
human
metapneumoviru
mpv
human
rhinoviru
hrv
adenoviru
adv
detect
use
singletub
realtim
revers
transcript
pcr
strategi
onestep
rtpcr
kit
appli
biosystem
usa
pcr
amplif
perform
use
realtim
pcr
system
appli
biosystem
usa
accord
manufactur
instruct
nasal
mucu
specimen
cultur
accord
china
nation
standard
protocol
detect
respiratori
bacteri
fungi
coloni
identif
undertaken
use
vitek
compact
system
franc
nine
bacteria
measur
includ
acinetobact
baumannii
enterobact
aerogen
escherichia
coli
klebsiella
ornithinolytica
klebsiella
pneumonia
pseudomona
aeruginosa
staphylococcu
aureu
staphylococcu
haemolyticu
bordetella
pertussi
one
fungu
yeast
also
detect
patient
serum
collect
place
mycoplasma
pneumonia
chlamydia
pneumonia
antibodi
igm
detect
commerci
kit
kanghua
china
accord
instruct
use
diagnost
respiratori
panel
multiplex
pcr
system
usa
detect
virus
three
pathogen
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
accord
packag
insert
data
analyz
spss
agreement
assay
measur
use
kappa
statist
sensit
specif
also
compar
test
patient
enrol
januari
septemb
studi
compris
adult
n
pediatr
n
patient
femalemal
ratio
patient
studi
could
receiv
treatment
antibiot
cephalosporin
astaxanthin
sulbactam
resp
antivir
drug
oseltamivir
ribavirin
combin
alon
four
case
patient
lung
diseas
case
patient
system
diseas
cough
fever
short
breath
dyspnea
frequent
symptom
observ
patient
gener
charact
present
tabl
preval
rsv
hrv
influenza
virus
b
detect
sampl
coronavirus
detect
sampl
sampl
adv
sampl
mpv
sampl
tabl
virus
mpv
flu
flu
b
two
method
good
agreement
coincid
rate
disagr
found
specimen
posit
result
test
one
two
assay
filmarray
rp
case
multipl
pcr
case
filmarray
rp
positivepcr
neg
seen
case
adv
case
hrv
case
rsv
multipl
pcr
positivefilmarray
rp
neg
observ
case
piv
case
rsv
tabl
studi
filmarray
rp
detect
posit
virus
adv
mpv
hrv
flu
flu
b
rsv
resp
total
pathogen
confirm
realtim
pcr
comparison
filmarray
rp
multipl
pcr
mpv
flu
flu
b
rsv
show
satisfactori
agreement
kappa
posit
virus
except
adv
hrv
kappa
kappa
total
filmarray
rp
multipl
pcr
significantli
high
sensit
specif
detect
respiratori
virus
compar
multipl
pcr
sensit
filmarray
rp
rsv
differ
sensit
respect
tabl
dual
viral
infect
detect
specimen
tabl
among
case
dual
viral
infect
found
method
case
detect
filmarray
rp
alon
case
detect
multipl
pcr
dual
viral
infect
major
rsv
combin
respiratori
virus
total
case
rsv
hrv
posit
case
rsv
adv
posit
case
rsv
flu
posit
case
rsv
posit
case
rsv
posit
case
rsv
posit
case
data
indic
filmarray
rp
detect
virus
multipl
pcr
especi
dual
viral
infect
intriguingli
nondetect
viru
pcr
assay
concentr
rsv
accompani
respiratori
viru
bacteria
fungi
detect
cultur
method
studi
result
show
bacteria
fungi
posit
specimen
filmarray
rp
detect
bordetella
pertussi
hard
method
evalu
two
method
studi
case
bordetella
pertussi
detect
filmarray
rp
howev
bordetella
pertussi
isol
cultur
method
mycoplasma
pneumonia
found
specimen
detect
filmarray
rp
serolog
test
mycoplasma
pneumonia
neg
tabl
microorgan
measur
integr
part
cap
patient
manag
accur
rapid
etiolog
diagnosi
help
prevent
secondari
infect
prevent
use
unnecessari
antibiot
facilit
time
use
antivir
drug
shorten
hospit
stay
studi
even
bacteri
fungal
cultur
antibodi
igm
detect
multipl
pcr
filmarray
rp
case
cap
could
find
pathogen
multiplex
realtim
pcr
detect
broad
spectrum
respiratori
microorgan
promptli
make
possibl
clinician
treat
patient
specif
antimicrobi
agent
howev
main
limit
pcr
method
includ
handl
whole
batch
sampl
least
sampl
cost
labor
save
differ
box
extract
train
special
biologist
may
main
reason
dnarna
extract
amplif
easili
contamin
result
interpret
frequenc
fals
posit
fals
neg
result
hinder
use
pcr
clinic
practic
thu
pcr
appropri
instant
point
care
especi
sever
patient
compar
multipl
pcr
measur
time
filmarray
rp
need
hour
need
experi
batch
singl
test
set
make
meet
requir
clinician
decid
whether
patient
quarantin
viru
flu
rapid
diagnosi
may
help
prevent
secondari
spread
benefici
prevent
viru
nosocomi
transmiss
children
adult
neuraminidas
inhibitor
reduc
median
time
resolut
symptom
day
administ
within
h
onset
symptom
earli
use
neuraminidas
inhibitor
reduc
develop
complic
pneumonia
point
filmarray
rp
offer
potenti
advantag
patient
treatment
due
undevelop
immun
system
mix
infect
two
respiratori
virus
common
children
easili
detect
convent
method
henc
biolog
signific
dual
infect
current
well
understood
clinic
signific
analyz
associ
age
pathogen
studi
filmarray
rp
higher
sensit
detect
dual
viral
infect
multipl
pcr
similarli
previou
studi
rsv
predomin
viru
induc
sever
pneumonia
popul
found
common
caus
sever
respiratori
diseas
infant
rsa
flu
continu
major
caus
agent
dual
viral
infect
studi
detect
rate
rhinovirus
higher
respiratori
virus
though
role
pneumonia
still
question
preval
adenovirusassoci
cap
fairli
low
similar
previou
studi
type
infect
import
recogn
might
induc
sever
fatal
necrot
pneumonia
especi
serotyp
pcr
substanti
sensit
identif
adenoviru
antigen
detect
due
wide
rang
pathogen
respons
cap
moder
sever
infect
broadspectrum
antimicrobi
cover
initi
deescal
narrow
spectrum
pathogendirect
agent
microbiolog
diagnosi
made
abil
differenti
viral
bacteri
pneumonia
could
import
signific
patient
manag
may
help
clinician
treat
patient
promptli
appropri
hospit
uncommon
mix
bacterialvir
coinfect
bacteri
cultur
identifi
posit
combin
viral
infect
frequent
ignor
clinician
hand
decis
prescrib
antibiot
may
influenc
lag
diagnosi
especi
children
empir
antibiot
therapi
almost
alway
initi
patient
immunocompromis
concern
sever
diseas
previou
studi
mycoplasma
pneumonia
caus
agent
communityacquir
atyp
pneumonia
chlamydophila
pneumonia
oblig
intracellular
bacterium
caus
acut
respiratori
infect
common
caus
cap
use
serolog
method
detect
mycoplasma
pneumonia
chlamydia
pneumonia
rather
cultur
mycoplasma
pneumonia
chlamydia
pneumonia
detect
cultur
highli
specif
complex
process
long
turnaround
time
technic
demand
offer
limit
sensit
serolog
pcr
method
may
provid
rapid
diagnosi
limit
serolog
method
includ
chlamydia
pneumonia
igm
igg
reactiv
might
caus
heterotyp
antibodi
test
evid
unabl
discrimin
past
persist
infect
previous
weak
posit
result
frequent
observ
mycoplasma
pneumonia
chlamydia
pneumonia
detect
lab
reason
need
clarif
compar
method
mention
filmarray
rp
high
specif
sensit
could
obtain
result
short
time
consid
cost
reagent
filmarray
rp
expens
multipl
pcr
reagent
consum
cost
rmb
filmarray
rp
multipl
pcr
calcul
per
patient
respect
howev
filmarray
rp
essenti
administr
appropri
antivir
therapi
dramat
shorten
handson
time
hour
versu
hour
reduct
averag
time
discontinu
oseltamivir
result
cost
save
approxim
us
per
patient
addit
filmarray
rp
result
overal
decreas
durat
antibiot
use
half
day
shorter
stay
quarter
day
less
hospit
follow
admiss
reduc
time
spent
isol
third
day
less
patient
viral
posit
implement
filmarray
rp
therefor
clinic
signific
far
beyond
cost
compar
multipl
pcr
filmarray
rp
provid
instant
care
test
result
simplifi
enhanc
workflow
compar
laboratorydevelop
pcr
ldpcr
last
decad
emerg
sever
acut
respiratori
syndrom
sar
avian
influenza
viru
pandem
influenza
viru
reemphas
import
role
respiratori
virus
caus
sever
pneumonia
nowaday
newli
discov
virus
includ
bocaviru
novel
coronavirus
rhinovirus
increasingli
recogn
caus
respiratori
ill
lead
extens
use
filmarray
rp
detect
novel
virus
one
limit
filmarray
rp
modifi
accord
need
clinician
laboratori
could
add
new
virus
detect
panel
like
multipl
pcr
anoth
limit
filmarray
rp
detect
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
complic
bacteri
fungal
cultur
coexit
viralbacteri
fungi
infect
henc
point
bacteri
fungal
cultur
essenti
ration
antibiot
select
treatment
success
